NDAORALSOLUTION
Approved
Dec 2024
Lifecycle
Growth
Competitive Pressure
0/100
Mechanism of Action
alpha-2-adrenergic receptor agonist and presumably reduces spasticity by increasing presynaptic inhibition of motor neurons. The effects of tizanidine are greatest on polysynaptic pathways. The overall effect of these actions is thought to reduce facilitation of spinal motor neurons.
Indications (1)
Loss of Exclusivity
LOE Date
May 7, 2042
196 months away
Patent Expiry
May 7, 2042
Company
Biofidelity
UK - Cambridge